A Trial to Investigate the Bioequivalence of Norditropin® (Somatropin) Versus Genotropin® (Somatropin) in Healthy Adult Subjects

Inclusion Criteria: * Healthy subjects at trial entry with no previous exposure to recombinant human growth hormone or IGF-I (insulin-like growth factor-I) * Body mass index (BMI) 18.0-27.0 kg/m\^2 (both inclusive) * Considered generally healthy upon completion of medical history, physical examination, vital signs, screening laboratory results, and electrocardiogram (ECG), as judged by the investigator Exclusion Criteria: * The receipt of any investigational medicinal product within 1 month prior to this trial * Current or previous treatment with growth hormone or IGF-I * Female of childbearing potential who is pregnant, breast-feeding or intends to become pregnant or is not using adequate contraceptive methods (adequate contraceptive measures as required by local law or practice) for the duration of the trial * Known presence or history of malignancy * Diabetes mellitus * Use of systemic corticosteroids * Use of anabolic steroids * History of drug or alcohol abuse